arrow
I

Ilan Goldenberg

Feinberg School of Medicine
H指数:60
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prioritizing Discovery and Advancements in Arrhythmia Therapies NIH/NHLBI Workshop

优先考虑心律失常治疗领域的发现与进展:NIH/NHLBI研讨会

2026-06-010
PRE
Rationale and Design of the Comparative Effectiveness of ICD Versus Non-ICD Therapy in Contemporary Heart Failure Patients at a Low Risk for Arrhythmic Death (CONTEMP-ICD) trial

RATIONALE AND DESIGN OF THE COMPARATIVE EFFECTIVENESS OF ICD VERSUS NON-ICD THERAPY IN CONTEMPORARY HEART FAILURE PATIENTS AT A LOW RISK FOR ARRHYTHMIC DEATH (CONTEMP-ICD)临床试验的原理与设计

2025-09-040
PRE
Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure

重新评估当代心力衰竭患者一级预防植入式心律转复除颤器的需求

2025-02-050
PRE
Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure

重新评估当代心力衰竭患者一级预防植入式心律转复除颤器的需求

2025-02-011
PRE
Risk of recurrent ventricular tachyarrhythmia following the occurrence of a first ventricular arrhythmic event in patients with a primary prevention implantable cardioverter-defibrillator

首次室性心律失常事件发生后,接受一级预防型植入式心律转复除颤器治疗的患者再次发生室性快速性心律失常的风险。

2024-11-220
PRE
Vigorous Exercise in Patients With Congenital Long QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS Study
2024-08-130
PRE
Risk Prediction in Male Adolescents With Congenital Long QT Syndrome: Implications for Sex-Specific Risk Stratification in Potassium Channel-Mediated Long QT Syndrome

先天性长QT综合征男性青少年的风险预测: 钾通道介导的长QT综合征的性别特异性风险分层的意义

2024-02-061
OAAI
Sex-Related Differences in Ventricular Tachyarrhythmia Events in Patients With Implantable Cardioverter-Defibrillator and Prior Ventricular Tachyarrhythmias
2024-02-012
OAAI
Upgrade of right ventricular pacing to cardiac resynchronization therapy in heart failure: a randomized trial

右心室起搏对心力衰竭心脏再同步治疗的升级: 一项随机试验

2023-08-2628
OAAI